Skip to main content

Table 1 Quantification of leukocyte subpopulations and of opioid-containing leukocytes in inflamed paws following intraplantar delivery of POMC-MIDGE-NLS.

From: Peripheral non-viral MIDGE vector-driven delivery of β-endorphin in inflammatory pain

Treatment

Total cell counts (× 103) per paw

 

Granulocytes

Monocytes/

macrophages

T cells

Opioid cells

control MIDGE-NLS

44 ± 13

823 ± 132

62 ± 12

403 ± 65

50 μg

    

POMC-MIDGE-NLS

    

25 μg

56 ± 19

566 ± 89

60 ± 14

262 ± 42

50 μg

92 ± 16

633 ± 56

51 ± 6

358 ± 38

100 μg

99 ± 40

691 ± 159

50 ± 11

379 ± 91

  1. Leukocyte counts were determined by flow cytometry. There were no significant differences between control MIDGE-NLS and POMC-MIDGE-NLS (p > 0.05, one-way ANOVA).